US FDA grants breakthrough therapy status for Lenvima in combo with Keytruda
Eisai Co., Ltd. and Merck, known as MSD outside the United States and Canada, announced that the US Food and Drug Administration... Read More
Insight on Bayer’s EU approval of new treatment regimen for Eylea
Bayer has received European Commission approval of a new treatment approach for Eylea to enable clinicians to combine proactive treatment with early... Read More
Case Study: LEO Pharma’s acquisition of Bayer’s dermatology unit
LEO Pharma has entered into a definitive agreement to buy Bayer’s global prescription dermatology unit. The portfolio to be acquired includes branded... Read More